vimarsana.com
  1. Home
  2. Live Updates
  3. Once Daily Dosin - Breaking News

Latest Breaking News On - Once daily dosin - Page 1 : vimarsana.com

Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting

TN-301 Demonstrates Tolerability, Potential for Once Daily Dosing, Target Engagement and Selectivity for HDAC6 in Phase 1 Clinical Trial of Healthy Participants 

United statesWhit tingleyTenaya therapeutics incAdministration of inhibitorsHeart failure society of americaTenaya therapeuticsFailure societyAnnual scientificChief medicalDemonstrate safetyTarget engagementOnce daily dosinHighly selectiveShows target engagementBenefit observedAdditive improvements

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.